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INTRODUCTION
On August 21, 1996, President Clinton signed the Health Insurance
Portability and Accountability Act of 1996 (HIPAA) into law.1 Over the past
two decades, the federal Department of Health and Human Services (HHS)
has published several sets of rules2 implementing the Administrative
Simplification provisions within HIPAA3 as well as the Health Information
* Lehman Professor of Law and Director, Health Law Program, William S. Boyd School of
Law, University of Nevada, Las Vegas. I thank Daniel Hamilton, Dean, William S. Boyd
School of Law, for his generous financial support of this research project and Emma Babler,
Research Librarian, Wiener-Rogers Law Library, for locating many of the sources referenced
in this Article. Finally, I thank the organizers, participants, and attendees of the Seton Hall
Law Review Symposium (“The New EU Data Protection Regulation: Transnational
Enforcement and Its Effects on US Businesses”) for their comments, questions, and ideas
regarding this Article.
1
Health Insurance Portability and Accountability Act of 1996 (HIPAA), Pub. L. No.
104-191, 110 Stat. 1936 (1996).
2
See infra notes 20–35 (referencing several sets of proposed, interim final, and final
rules).
3
HIPAA §§ 261–64 [hereinafter Administrative Simplification Provisions].
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Technology for Economic and Clinical (HITECH) Act within the American
Recovery and Reinvestment Act (ARRA), signed into law by President
Obama on February 17, 2009.4 These rules include a final rule governing
the use and disclosure of protected health information by covered entities
and their business associates (Privacy Rule).5
On January 25, 2012, the European Commission proposed to protect
individuals with regard to the processing of personal data and the free
movement of such data.6 The European Union’s (EU’s) final General Data
Protection Regulation (GDPR) was published in the Official Journal of the
European Union on May 4, 2016,7 and will apply beginning May 25, 2018.8
This Article compares and contrasts three illustrative concepts and
rights in the Privacy Rule and/or the GDPR, including the concepts of
authorization and consent, the rights of amendment and rectification, and the
right to erasure. Identified similarities reflect the core values of HHS and
the EU with respect to maintaining the confidentiality and privacy of
personal data and protected health information, respectively. Identified
differences reflect the Privacy Rule’s original, narrow focus on health
industry participants and individually identifiable health information
compared to the GDPR’s broad focus on data controllers and personal data.
Other differences reflect, perhaps, the U.S. health care industry’s significant
experience with heavy regulation, the health care industry’s willingness to
accept additional regulation in furtherance of the course of business, and
specific concerns about the ways in which employers, insurers, and other
institutions have used individuals’ health information to their detriment.
This Article proceeds as follows: Part I summarizes the history of the
Privacy Rule, including the many proposed rules, interim final rules, final
rules, guidance documents, and resolution agreements published by HHS.9
Part II reviews the Privacy Rule’s theory of and approach to health
information confidentiality, including the Privacy Rule’s three rules of
4
See American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, § 13001–
24, 123 Stat. 115 (2009) (containing the Health Information Technology for Economic and
Clinical Health (HITECH) Act).
5
Privacy of Individually Identifiable Health Information, 45 C.F.R. §§ 164.500–
164.534 (2016).
6
Commission of the European Communities, Proposal for a Regulation of the European
Parliament and of the Council on the Protection of Individuals with Regard to the Processing
of Personal Data and on the Free Movement of Such Data (General Data Protection
Regulation), COM (2012) 11 final (Jan. 2012).
7
Council Regulation (EU) 2016/679 of the European Parliament and of the Council of
27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal
Data and on the Free Movement of Such Data, and repealing Directive 95/46/EC (General
Data Protection Regulation), 2016 O.J. (L 119) 1 [hereinafter EU GDPR].
8
Id. art. 99, ¶ 2 (“It shall apply from 25 May 2018.”).
9
See infra Part I.
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individual permission, one of which must be satisfied before a covered entity
or business associate internally uses or externally discloses an individual’s
protected health information.10 Part III compares and contrasts the concepts
of authorization and consent under the Privacy Rule and the GDPR,
respectively.11 Part IV focuses on the rights of amendment and rectification
in the Privacy Rule and GDPR, respectively.12 Part V examines the GDPR’s
right to erasure, also known as the right to be forgotten.13 This Article
concludes by assessing the similarities and differences between these two
regulations in these three contexts and explaining the differences with
reference to principles of health law that may not broadly apply to non-health
industries.
I. HISTORY OF THE HIPAA PRIVACY RULE
As signed into law by President Clinton on August 21, 1996, HIPAA
had several purposes, including improving portability and continuity of
health insurance coverage in the individual and group markets, combating
health care fraud and abuse, promoting the use of medical savings accounts,
improving access to long-term care services and insurance coverage, and
simplifying the administration of health insurance.14 The Administrative
Simplification Provisions, codified at Subtitle F of Title II of HIPAA,15
directed HHS to issue regulations protecting the privacy16 of individually
10

See infra Part II.
See infra Part III.
12
See infra Part IV.
13
See infra Part V.
14
See Health Insurance Portability and Accountability Act of 1996 (HIPAA), Pub. L.
No. 104-191, 110 Stat. 1936, at Preface (1996) (“An Act [t]o amend the Internal Revenue
Code of 1986 to improve portability and continuity of health insurance coverage in the group
and individual markets, to combat waste, fraud, and abuse in health insurance and health care
delivery, to promote the use of medical savings accounts, to improve access to long-term care
services and coverage, to simplify the administration of health insurance, and for other
purposes.”). The Author has reviewed the history of and the regulatory approach taken in the
Privacy Rule in a number of prior scholarly articles. See, e.g., Stacey A. Tovino, Hospital
Chaplaincy under the HIPAA Privacy Rule: Health Care or “Just Visiting the Sick?”, 2 IND.
HEALTH L. REV. 51 (2005); Stacey A. Tovino, Medical Privacy, in GOVERNING AMERICA:
MAJOR DECISIONS OF FEDERAL, STATE, AND LOCAL GOVERNMENTS FROM 1789 TO PRESENT
(Paul Quirk & William Cunion eds., 2011); Stacey A. Tovino, HIPAA Privacy for Physicians,
17 PATHOLOGY CASE REV. 160 (2012); Stacey A. Tovino, Gone Too Far: Federal Regulation
of Health Care Attorneys, 91 OR. L. REV. 813 (2013); Stacey A. Tovino, Silence Is Golden . . .
Except in Health Care Philanthropy, 48 U. RICH. L. REV. 1157 (2014); Stacey A. Tovino,
Complying with the HIPAA Privacy Rule: Problems and Perspectives, 1 LOY. U. CHI. J. REG.
COMPLIANCE (2016); Stacey A. Tovino, Teaching the HIPAA Privacy Rule, 61 ST. LOUIS U.
L.J. (forthcoming 2017). With technical and conforming changes, much of Parts I and II of
this Article are reprinted from these prior scholarly articles with the Author’s permission.
15
See Health Insurance Portability and Accountability Act of 1996 (HIPAA), Pub. L.
No. 104-191, §§ 261–64, 110 Stat. 1936 (1996).
16
Elsewhere, the Author defined and distinguished the concepts of privacy and
11
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identifiable health information if Congress failed to enact comprehensive
privacy legislation within three years of HIPAA’s enactment.17 When
Congress failed to enact privacy legislation by its deadline, HHS incurred
the duty to adopt privacy regulations.18 The original HIPAA statute clarified,
however, that any privacy regulations adopted by HHS must be made
applicable only to three classes of individuals and institutions: (1) health
plans; (2) health care clearinghouses; and (3) health care providers who
transmit health information in electronic form in connection with certain
standard transactions (collectively, covered entities).19
HHS responded. On November 3, 1999,20 and December 28, 2000,21
HHS issued a proposed and final privacy rule (“Privacy Rule”) regulating
covered entities’ uses and disclosures of protected health information (PHI).
On March 27, 2002,22 and August 14, 2002,23 HHS issued proposed and final
confidentiality for purposes of discussions addressing the legal responsibilities of health
industry participants. See, e.g., Stacey A. Tovino, Functional Magnetic Resonance
Information: A Case for Neuro Exceptionalism?, 34 FLA. ST. U. L. REV. 415, Parts III(J), IV
& V (2007). This Article uses the same definitions and distinctions. Privacy refers to an
individual’s interest in avoiding the unwanted collection by a third party of health or other
information about the individual. Id. Confidentiality, on the other hand, refers to the
obligation of a health industry participant to prevent the unauthorized or otherwise
inappropriate use or disclosure of voluntarily given and appropriately gathered health and
other information relating to an individual. Id. Although the Privacy Rule actually is a health
information confidentiality rule—because it sets limits on how health care providers and other
covered entities can use and disclose appropriately gathered PHI—the Author uses the phrase
“Privacy Rule” and the word “privacy” in this Article because these are the phrases and words
selected by HHS and used by the public for the rule and the concepts addressed therein. See,
e.g., Health Information Privacy, U.S. DEP’T HEALTH & HUM. SERVS., https://www.hhs.gov
/hipaa/ (last visited Feb. 13, 2017).
17
HIPAA § 264 (“If legislation governing standards with respect to the privacy of
individually identifiable health information . . . is not enacted by the date that is 36 months
after the date of the enactment of this Act, the Secretary of Health and Human Services shall
promulgate final regulations containing such standards . . .”).
18
See id.
19
Id. § 262(a) (“Any standard adopted under this part shall apply, in whole or in part, to
the following persons: ‘(1) A health plan. (2) A health care clearinghouse. (3) A health care
provider who transmits any health information in electronic form in connection with a
transaction referred to in section 1173(a)(1).’”). See Standards for Privacy of Individually
Identifiable Health Information, 64 Fed. Reg. at 59,918. See generally Standards for Privacy
of Individually Identifiable Health Information, 64 Fed. Reg. 59,918 & 59,924 (proposed
Nov. 3, 1999) (to be codified at 45 C.F.R. pts. 160–64) (explaining that HHS did not directly
regulate any entity that was not a covered entity because it did not have the statutory authority
to do so).
20
Id.
21
Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462 (Dec. 28, 2000).
22
Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg.
14,776 (proposed Mar. 27, 2002) (to be codified at 45 C.F.R. pts. 160–64).
23
Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg.
53,182 (Aug. 14, 2002).
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modifications to the Privacy Rule. With the exception of technical
corrections and conforming amendments,24 these rules as reconciled
remained largely unchanged between 2002 and 2009.
The nature and scope of the legal duties of confidentiality that applied
to covered entities and their business associates (BAs)25 changed
significantly eight years ago. On February 17, 2009, President Obama
signed ARRA into law.26 Division A, Title XIII of ARRA, better known as
HITECH, contained certain provisions requiring HHS to modify some of the
information use and disclosure requirements and definitions set forth in the
Privacy Rule, adopt new breach notification rules, and amend the civil
penalty amounts that may be imposed on covered entities and BAs who
violate the Privacy Rule.27
Since ARRA’s enactment, HHS has issued several sets of proposed
rules, interim final rules, final rules, and technical corrections both
implementing HITECH’s required changes to the Privacy Rule as well as
responding to other national health information confidentiality concerns. On
August 24, 2009, for example, HHS released an interim final rule
implementing HITECH’s new breach notification requirements.28 On
24

See, e.g., Standards for Privacy of Individually Identifiable Health Information,
Correction of Effective and Compliance Dates, 66 Fed. Reg. 12,434 (Feb. 26, 2001);
Technical Corrections to the Standards for Privacy of Individually Identifiable Health
Information Published December 28, 2000, 65 Fed. Reg. 82,944 (Dec. 29, 2000).
25
Business associates (BAs) are defined to include individual and institutions who: (1)
on behalf of a covered entity, but other than in the capacity of a member of the workforce of
a covered entity, create, receive, maintain, or transmit PHI for a function or activity regulated
by the HIPAA Privacy Rule; and (2) provide, other than in the capacity of a member of the
workforce of such covered entity, legal, actuarial, accounting, consulting, data aggregation,
management, administrative, accreditation, or financial services to or for the covered entity.
See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification
Rules Under the Health Information Technology for Economic and Clinical Health Act and
the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules, 78
Fed. Reg. 5,566, 5,688 (Jan. 25, 2013) (adopting 45 C.F.R. § 160.103 and providing a new
definition of business associate).
26
See American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, § 13001–
24, 123 Stat. 115 (2009).
27
Id. Elsewhere, the Author critiqued HITECH’s imposition of confidentiality
requirements directly on BAs and proposed statutory and regulatory changes to HITECH and
the HIPAA Privacy Rule, respectively, that would except a class of BAs, including outside
counsel, from the confidentiality obligations imposed on other BAs. See Stacey A. Tovino,
Gone Too Far: Federal Regulation of Health Care Attorneys, 91 OR. L. REV. 813, 813–67
(2013). Elsewhere, the Author also critiqued HITECH’s loosening of the regulatory provision
that governs covered entities’ uses and disclosures of protected health information for
fundraising purposes. See Stacey A. Tovino, Silence Is Golden . . . Except in Health Care
Philanthropy, 48 U. RICH. L. REV. 1157 (2014). This Article builds on the Author’s earlier
work in a new dimension; that is, by comparing illustrative provisions in the HIPAA Privacy
Rule to the EU GDPR.
28
Breach Notification for Unsecured Protected Health Information, 74 Fed. Reg. 42,740
(Aug. 24, 2009).
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October 30, 2009, HHS released an interim final rule implementing
HITECH’s strengthened enforcement provisions, including strengthened
civil monetary penalties that the federal Office for Civil Rights (OCR) may,
for the first time since the enactment of the HIPAA statute, impose directly
on BAs who fail to maintain the confidentiality of PHI.29 On May 31, 2011,
HHS released a proposed rule that would modify the HIPAA Privacy Rule’s
accounting of disclosures requirement.30 On January 25, 2013, HHS
released a final rule modifying the HIPAA Privacy, Security, Breach
Notification, and Enforcement Rules in accordance with HITECH (“Final
Regulations”).31 On June 7, 2013, HHS released technical corrections to the
Final Regulations.32 On September 16, 2013, HHS released a Model Notice
of Privacy Practices designed to assist covered entities in complying with the
Final Regulations.33 On February 6, 2014, HHS released a final rule
modifying the Privacy Rule to provide individuals with a right to receive
their laboratory test results directly from their testing laboratories.34 Most
recently, on January 6, 2016, HHS released a final rule that modifies the
Privacy Rule and permits certain covered entities to disclose PHI to the
National Instant Criminal Background Check System.35
As of this writing, HHS has also released fifty-one resolution
agreements and notices of final determination.36 In these agreements and
notices, covered entities resolve to comply with the Privacy Rule, report to
HHS regarding its compliance with the Privacy Rule, pay a resolution
amount, and/or pay a civil money penalty.37 For example, on February 1,
29

2009).

HIPAA Administrative Simplification: Enforcement, 74 Fed. Reg. 56,123 (Oct. 30,

30
HIPAA Privacy Rule Accounting of Disclosures Under the Health Information
Technology for Economic and Clinical Health Act, 76 Fed. Reg. 31,426 (proposed May 31,
2011) (to be codified at 45 C.F.R. pt. 164).
31
See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach
Notification Rules Under the Health Information Technology for Economic and Clinical
Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the
HIPAA Rules, 78 Fed. Reg. 5566, 5566 (Jan. 25, 2013).
32
See Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules,
78 Fed. Reg. 34,264, 34,266 (June 7, 2013).
33
Model Notices of Privacy Practices, U.S. DEP’T HEALTH & HUMAN SERVS.,
http://www.hhs.gov/hipaa/for-professionals/privacy/guidance/model-notices-privacypractices/ (last visited Apr. 17, 2017).
34
CLIA Program and HIPAA Privacy Rule; Patients’ Access to Test Reports, 79 Fed.
Reg. 7290 (Feb. 6, 2014).
35
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and the
National Instant Criminal Background Check System (NICS), 81 Fed. Reg. 382, 396 (Jan. 6,
2016).
36
See Resolution Agreements, U.S. DEP’T HEALTH & HUMAN SERVS., http://www.hhs
.gov/hipaa/for-professionals/compliance-enforcement/agreements/index.html (last visited
Apr. 17, 2017).
37
See id.

TOVINO (DO NOT DELETE)

2017]

8/8/2017 7:09 PM

THE HIPAA PRIVACY RULE AND THE EU GDPR

979

2017, HHS issued a press release announcing a recent notice of final
determination, which imposed a civil money penalty (CMP) on Children’s
Medical Center of Dallas (“Children’s”).38 As background, a workforce
member of Children’s lost an unencrypted, non-password-protected
BlackBerry device that contained the PHI of approximately 3,800
individuals at the Dallas/Fort Worth International Airport.39 In addition, an
unencrypted laptop containing the PHI of 2,462 individuals was stolen from
Children’s premises.40 Although Children’s had implemented some physical
safeguards to protect its laptop storage area, Children’s admitted it provided
access to the area to workforce personnel not authorized to access PHI.41 By
letter dated January 18, 2017, HHS imposed a $3,217,000.00 CMP on
Children’s for these two health information confidentiality breaches as well
as several other Privacy Rule violations.42
II. THE HIPAA PRIVACY RULE’S THEORY OF AND APPROACH TO HEALTH
INFORMATION CONFIDENTIALITY
A brief summary of the Privacy Rule’s theory and approach to health
information confidentiality is necessary before proceeding to Part III, which
compares and contrasts the concepts of authorization and consent under the
Privacy Rule and the GDPR, respectively.
The Privacy Rule’s goal is to balance the interest of individuals in
maintaining the confidentiality of their health information with the interests
of society in obtaining, using, and disclosing health information to carry out
a variety of public and private activities.43 To this end, the Privacy Rule
regulates covered entities’ and BAs’ uses of, disclosures of, and requests for
individually identifiable health information (IIHI)44 to the extent such
38

Press Release, U.S. Dep’t Health & Hum. Servs., Lack of Timely Action Risks
Security and Costs Money (Feb. 1, 2017).
39
Id.
40
Id.
41
Id.
42
Letter from Jocelyn Samuels, Dir., Off. C.R., Dep’t Health & Hum. Servs., to Mr.
David Barry, Pres., Sys. Clinical Operations, Children’s Med. Ctr. 1 (Jan. 18, 2017).
43
See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462, 82,464 (Dec. 28, 2000) (“The rule seeks to balance the needs of the individual
with the needs of the society.”); id. at 82,468 (“The task of society and its government is to
create a balance in which the individual’s needs and rights are balanced against the needs and
rights of society as a whole.”); id. at 82,472 (“The need to balance these competing interests—
the necessity of protecting privacy and the public interest in using identifiable health
information for vital public and private purposes—in a way that is also workable for the varied
stakeholders causes much of the complexity in the rule.”).
44
The Privacy Rule defines “individually identifiable health information” (IIHI) as
“information that is a subset of health information, including demographic information
collected from an individual, and: (1) Is created or received by a health care provider, health
plan, employer, or health care clearinghouse; and (2) Relates to the past, present, or future
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information does not constitute: (1) an education record protected under the
Family Educational Rights and Privacy Act of 1974 (FERPA); (2) a student
treatment record excepted from protection under FERPA; (3) an employment
record held by a covered entity in its role as an employer; or (4) individually
identifiable health information regarding a person who has been deceased
for more than fifty years.45 The Privacy Rule calls the subset of IIHI
described in the previous sentence “protected health information.”46
Before using or disclosing PHI, the Privacy Rule requires covered
entities and BAs to adhere to one of three different rules depending on the
purpose of the information use or disclosure.47 These rules reflect HHS’s
desire to appropriately balance the interest of individuals in maintaining the
confidentiality of their PHI with a wide range of societal interests in
obtaining, using, or disclosing PHI, some of which may have greater societal
importance and value than others.48
The first rule allows covered entities and BAs to use and disclose PHI
with no prior permission from the individual who is the subject of the PHI—
but only in certain situations. That is, covered entities may freely use and
disclose PHI without any form of prior permission in order to carry out their

physical or mental health or condition of an individual; the provision of health care to an
individual; or the past, present, or future payment for the provision of health care to an
individual; and (i) That identifies the individual; or (ii) With respect to which there is a
reasonable basis to believe the information can be used to identify the individual.” General
Administrative Requirements, 45 C.F.R. § 160.103 (2016).
45
Id. (defining “protected health information”).
46
Id. (using the phrase “protected health information”).
47
Standard Unique Health Identifier for Health Plans, 45 C.F.R. §§ 164.502–164.514
(2016) (setting forth the use and disclosure requirements applicable to covered entities and
business associates).
48
See supra text accompanying note 43.
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own treatment,49 payment,50 and health care operations51 activities,52 as well
as certain public benefit activities.53
As an example of this first rule, a covered general practitioner (GP) who
wishes to consult with a specialist to treat a patient may disclose PHI to the
specialist, and the Privacy Rule does not require the patient to give the GP
prior authorization for the disclosure.54 Likewise, a covered hospital that
treats a patient may send a bill to the patient’s insurer to obtain payment for
hospital services rendered without the patient’s prior authorization.55
Similarly, a teaching physician employed by a covered academic medical
center may involve medical students, interns, residents, and fellows in
patient care, without prior authorization from the patients who are receiving
such care, to enable the students and residents to learn to practice medicine.56
Furthermore, a covered entity that is required by state or other law to disclose
PHI to another individual or entity may do so without patient authorization.57
49

The Privacy Rule defines “treatment” as:
[T]he provision, coordination, or management of health care and related
services by one or more health care providers, including the coordination or
management of health care by a health care provider with a third party;
consultation between health care providers relating to a patient; or the referral
of a patient for health care from one health care provider to another.
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.501 (2016).
50
The Privacy Rule defines “payment” as the activities “undertaken by a health plan to
obtain premiums or to determine or fulfill its responsibility for coverage and provision of
benefits under the health plan” as well as the activities of a “health care provider or health
plan to obtain or provide reimbursement for the provision of health care.” Id.
51
The Privacy Rule defines “health care operations” with respect to a list of activities
that are related to a covered entity’s covered functions. See id. (defining health care
operations). These activities include, but are not limited to, conducting quality assessment
and improvement activities, conducting training programs in which medical and other health
care students learn to practice health care under supervision, and arranging for the provision
of legal services. See id.
52
See id. § 164.506(c)(1) (permitting a covered entity to use or disclose PHI for its own
treatment, payment, or health care operations).
53
Covered entities may use and disclose PHI for twelve different public policy activities
without the prior written authorization of the individual who is the subject of the information.
See id. § 164.512(a)–(l). These public policy activities include, but are not limited to, uses
and disclosures required by law, uses and disclosures for public health activities, disclosures
for law enforcement activities, uses and disclosures for research, and disclosures for workers’
compensation activities. See id. § 164.512(a), (c), (b), (f), (i) & (l).
54
See id. § 164.501 (defining “treatment” to include “consultations between health care
providers relating to a patient”).
55
See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.501
(2016) (defining “payment” to include “the activities undertaken by a health care provider . . .
to obtain . . . reimbursement for the provision of health care”); id. § 164.506(c)(1) (permitting
a covered entity to disclose PHI for its own payment activities).
56
See id. § 164.501(c)(1) (defining “health care operations” to include “conducting
training programs in which students, trainees, or practitioners in areas of health care learn
under supervision to practice or improve their skills as health care providers”).
57
See id. § 164.512(a)(1) (allowing covered entities to “use or disclose protected health
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By final illustrative example, a covered entity may disclose a patient’s PHI
to a law enforcement officer in certain situations, including when the covered
entity suspects that the death of the patient may have resulted from criminal
conduct.58 The theory behind these permitted information uses and
disclosures is that treating patients, allowing health care providers to obtain
reimbursement for providing health care, training medical students and
residents, complying with state law, and alerting law enforcement officers to
the suspicion of criminal activity outweigh an individual’s interest in
maintaining complete confidentiality of his or her PHI.
The first rule requires no prior authorization from the individual who is
the subject of the information before the information use or disclosure may
occur.59 Under the second rule, a covered entity may use and disclose an
individual’s PHI for certain activities, but only if the individual is informed
in advance of the use or disclosure and has the opportunity to agree to,
prohibit, or restrict the use or disclosure.60 Because the Privacy Rule allows
the covered entity to orally inform the individual of (and capture an oral
agreement or oral objection to) a use or disclosure permitted by these
provisions, this second rule is sometimes referred to as the “oral permission
rule,” although a more practical written permission also will suffice.
Under the second rule, a covered entity may conduct five sets of
information uses and disclosures once the individual who is the subject of
the information has been notified and has either agreed or not objected to the
information use or disclosure.61 These five sets of information uses and
disclosures include: (1) certain uses and disclosures of directory information,
such as name, location, general condition, and religious affiliation;62 (2)
certain uses and disclosures that would allow other persons to be involved in
a patient’s care or payment for care;63 (3) certain uses and disclosures that
would help notify, or assist in the notification of, family members, personal
representatives, and other persons responsible for the care of the individual’s
location, general condition, or death;64 (4) certain uses and disclosures for
disaster relief purposes;65 and (5) certain disclosures to family members and
other persons who were involved in the individual’s care or payment for
information to the extent that such use or disclosure is required by law and the use or
disclosure complies with and is limited to the relevant requirements of such law”).
58
See id. § 164.512(f)(4).
59
See supra notes 54–58 and accompanying text.
60
See 45 C.F.R. § 164.510.
61
See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.510
(2016).
62
See id. § 164.510(a).
63
See id. § 164.510(b)(1)(i).
64
See id. § 164.510(b)(1)(ii).
65
See id. § 164.510(b)(4).
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health care prior to the individual’s death of PHI that is relevant to that
person’s involvement.66
As an illustration of the second rule, the hospital room number and
general condition of a patient (e.g., “good,” “fair,” “poor,” “stable”) who has
given his or her permission or who has not expressed an objection may be
disclosed to a visitor who requests directory information about that patient.67
Likewise, a woman in labor who wishes her partner to be present for her
labor and delivery may orally give her permission for her health care
providers to involve her partner in her care.68
The theory behind requiring at least oral permission for these
information uses and disclosures is that the patient has an interest in
maintaining the confidentiality of his or her PHI; however, the patient also
may have an interest in being visited in the hospital, in obtaining assistance
with the patient’s health care or payment for health care, and being assisted
during a disaster. In addition, the patient’s family also may have an interest
in visiting the patient in the hospital, assisting the patient with his or her
health care and financial needs, and obtaining assistance during a disaster.
The required oral permission reflects the individual’s interest in maintaining
the confidentiality of his or her health information, but the lack of a
requirement for a formal written authorization reflects HHS’s desire to make
it easy for the individual to ask for or agree to receive help.
III. THE CONCEPTS OF AUTHORIZATION AND CONSENT
The third rule––a default rule––requires covered entities and BAs to
obtain the prior written authorization from the individual who is the subject
of the PHI before using or disclosing the individual’s PHI in any situation
that does not fit under the first or second rule.69 Stated another way, in the
event that a covered entity or BA would like to use or disclose PHI for a
purpose (1) that is not treatment, payment, or health care operations; (2) that
does not fall within one of twelve public benefit exceptions; (3) that is not
allowed with oral permission or without an objection; and (4) that is not
otherwise permitted or required by the Privacy Rule, the covered entity must
obtain the prior written authorization from the individual who is the subject
of the information.70

66

See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.501(b)(5)

(2016).
67
68
69
70

See id. § 164.510(a)(1), (2).
See id. § 164.510(b)(1)(i).
See id. § 164.508(a)(1).
See id. § 164.508(a)(1).
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A. Definitions, Conceptualizations, Content, and Format
The Privacy Rule does not formally define “authorization” in a
definition regulation; instead, the concept of authorization simply exists as a
default rule. The Privacy Rule does, however, specify the form of the
authorization required by the third rule, including certain elements and
statements that are designed to place the individual on notice of how the
individual’s PHI will be used or disclosed.71 These elements and statements
include:
(i) [a] description of the information to be used or disclosed that
identifies the information in a specific and meaningful fashion; (ii)
[t]he name or other specific identification of the person(s), or class
of persons, authorized to make the requested use or disclosure;
(iii) [t]he name or other specific identification of the person(s), or
class of persons, to whom the covered entity may make the
requested use or disclosure; (iv) [a] description of each purpose of
the requested use or disclosure; (v) [a]n expiration date or an
expiration event that relates to the individual or the purpose of the
use or disclosure; (vi) [s]ignature of the individual and date.72
The regulations also require: (i) a statement regarding the individual’s
right to revoke the authorization in writing together with the exceptions to
the right to revoke; (ii) a statement regarding the ability or inability of the
covered entity or BA “to condition treatment, payment, enrollment, or
eligibility for benefits on the authorization;” and (iii) a statement regarding
“the potential for information disclosed pursuant to the authorization to be
subject to redisclosure by the recipient and no longer be protected by [the
Privacy Rule.]”73 HIPAA-compliant authorization forms also must be
written in plain language.74
The high level of prior individual permission required by HIPAA’s
authorization form reflects the value HHS places on an individual’s interest
in maintaining the confidentiality of his or her PHI compared to other
societal interests that are far removed from the core functions of covered
entities and BAs. Some of the societal interests include a health care
provider’s interest in selling the patient’s information to a tabloid magazine
or a health plan’s interest in disclosing the patient’s information to a
marketing company to allow the company to market its products and services
to the individual.75
71

See id. § 164.508(c)(1), (2).
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.508(c)(1)
(2016) (listing six core elements).
73
Id. § 164.508(c)(2) (listing three required statements).
74
Id. § 164.508(c)(3).
75
See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462, 82,514 (Dec. 28, 2000) (“[C]overed entities must obtain the individual’s
72
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Unlike the Privacy Rule, which does not specifically define
“authorization,” the GDPR defines “consent” as any “freely given, specific,
informed and unambiguous indication of the data subject’s . . . agreement to
the processing of personal data relating to him or her.”76 Under the GDPR,
consent is less of a default concept and more of a primary requirement with
acceptable alternatives. That is, under the GDPR, the processing of personal
data shall be lawful only if and to the extent one of the following applies:
(a) the data subject has given consent . . .; (b) processing is
necessary for the performance of a contract to which the data
subject is party or in order to take steps at the request of the data
subject prior to entering into a contract; (c) processing is necessary
for compliance with a legal obligation to which the controller is
subject; (d) processing is necessary in order to protect the vital
interests of the data subject or of another natural person; (e)
processing is necessary for the performance of a task carried out
in the public interest or in the exercise of official authority vested
in the controller; or (f) processing is necessary for the purposes of
the legitimate interests pursued by the controller or by a third
party, except where such interests are overridden by the interests
or fundamental rights and freedoms of the data subject which
require protection of personal data, in particular where the data
subject is a child.77
With respect to the content of the consent, the GDPR only requires that
the data subject be made aware of “the fact that and the extent to which
consent is given.”78 For the subject’s consent to be considered informed, the
GDPR also requires the data subject to be aware of, at least, “the identity of
the controller and the purposes of the processing for which the personal data
are intended.”79
According to the GDPR, a consent that is created by the data controller
should be provided to the subject “in an intelligible and easily accessible
form, using clear and plain language and it should not contain unfair terms.”80
In terms of format, a consent for the processing of personal data—not data
concerning health—can be a written statement, as is required by the Privacy
Rule for the use or disclosure of PHI under the third rule of individual
permission; but it could also be satisfied by an electronic ticking of a box or

authorization before using or disclosing protected health information for marketing
purposes.”).
76
EU GDPR, supra note 7, art. 4(11).
77
Id. art. 6(1) (emphasis added).
78
Id. pmbl., ¶ 42.
79
Id.
80
Id.
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even an oral statement indicating agreement to personal data processing.81
In comparison, and as discussed in Part II, oral agreement to the use and
disclosure of PHI under the Privacy Rule is only permitted in the context of:
(1) disclosures of directory information; (2) disclosures to persons involved
in patients’ care and payment for care; (3) disclosures for notification
purposes; (4) disclosures for disaster relief purposes; and (5) disclosures
when the individual is deceased.82
Notwithstanding the GDPR’s loose conceptualization of and format for
the consent for the processing of personal data, the GDPR expressly prohibits
the processing of personal data concerning health unless the data subject has
given “explicit” consent or an exception applies.83 In addition, the GDPR
does allow Member States to maintain or introduce further limitations on the
processing of health data,84 much in the same way states in the U.S. are
permitted to have more stringent laws protecting health information
confidentiality relative to the Privacy Rule’s federal floor.85
B. Conditioning
To ensure that an individual’s prior written authorization for the use or
disclosure of his or her PHI under the Privacy Rule is freely given, the
Privacy Rule also contains a general “no conditioning” rule. That is, the
Privacy Rule generally prohibits covered entities from conditioning
treatment, payment, enrollment, or eligibility on an individual’s provision of
an authorization, although there are three exceptions.86 As discussed above,
an individual who signs an authorization for the use or disclosure of PHI
must be notified in the authorization form itself about the “no conditioning”
rule, the exceptions to the rule, and the consequences of a refusal to sign an
authorization form when conditioning is permitted.87
Here, the GDPR is similar although not quite as strong. In other words,
the GDPR does have a requirement that consent for the processing of
personal data be freely given.88 In assessing if consent is freely given, the
GDPR looks at three factors, including: (1) whether the data subject has

81

Id. ¶ 32.
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.510 (2016).
83
EU GDPR, supra note 7, art. 9, ¶ 2(a).
84
Id. art. 9, ¶ 4.
85
General Administrative Requirements, 45 C.F.R. § 160.203(b) (2016) (stating that the
Privacy Rule generally preempts a contrary provision of state law unless the state law is more
stringent than the Privacy Rule); id. § 160.202 (defining “more stringent”).
86
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.508(b)(4)
(2016). See infra note 94 and accompanying text for exceptions.
87
§ 164.508(c)(2)(ii)(A), (B).
88
EU GDPR, supra note 7, pmbl., ¶ 32; id., art. 4, ¶ 11.
82
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genuine, free choice in deciding whether to give consent;89 (2) whether the
data subject is unable to refuse to consent;90 and (3) whether the performance
of a contract is conditioned on the data subject’s consent when consent is not
necessary for the performance of the contract.91 The last factor expresses a
concern similar to that embodied in the Privacy Rule’s “no conditioning”
rule, which is the concern that individuals will be asked to cede their rights
to data privacy and information confidentiality in order to obtain a desired
or necessary service. The difference between the Privacy Rule and the
GDPR is the strength of the concern. HHS frames the concept as an outright
prohibition with only three exceptions, whereas the GDPR simply assesses
conditioning as an element of the voluntariness of consent.
C. Separation of Presentation
Another measure of comparison is the regulations’ separation of
presentation rules. To ensure that individuals who give their prior written
authorization know what they are signing and recognize the importance of
what they are signing, the Privacy Rule generally prohibits an authorization
from being combined with another document.92 Instead, the Privacy Rule
requires an authorization to be presented separately to each individuals for
his or her signature.93 Only three exceptions to this “no combination” rule
exist, and these exceptions involve: (1) authorizations combined with
research-related documentation; (2) two or more authorizations for the use
or disclosure of psychotherapy notes; and (3) two or more authorizations that
are not conditioned on treatment, payment, enrollment in a health plan, or
eligibility for benefits.94
The GDPR expresses similar concerns about the importance of a data
subject’s understanding his or her consent to data processing. The difference
is that the GDPR expressly permits the combination of a consent with
another “written declaration which also concerns other matters,” but only if
the “request for consent [is] presented in a manner which is clearly
distinguishable from the other matters.”95 Under the GDPR, then, the
consent does not need to be separate, just presented in a manner that is clearly
distinguishable.

89
90
91
92
93
94
95

Id. pmbl., ¶ 42.
Id.
Id. art. 7, ¶ 4.
45 C.F.R. § 164.508(b)(3) (2016).
See id. § 164.508(b)(3).
Id. § 164.508(b)(3)(i)–(iii).
EU GDPR, supra note 7, art. 7, ¶ 2.

TOVINO (DO NOT DELETE)

988

8/8/2017 7:09 PM

SETON HALL LAW REVIEW

[Vol. 47:973

D. Rights of Revocation and Withdrawal
Under the Privacy Rule, an individual generally has the right to revoke
an already-given authorization at any time so long as the revocation is in
writing.96 The Privacy Rule provides two exceptions to this right to revoke,
addressing situations in which: (1) the covered entity has already acted in
reliance on the authorization, including by using or disclosing PHI before the
revocation was received; and (2) an authorization was obtained as a
condition of obtaining insurance coverage and other law provides the insurer
with the right to contest a claim under the policy or the policy itself.97 The
Privacy Rule implements the right to revoke by requiring all authorizations
to contain a statement adequate to place the individual on notice of the
individual’s right to revoke the authorization, the exceptions to the right to
revoke, and a description of how the individual may revoke his or her
authorization.98
The GDPR has a similar concept known as withdrawal. That is, the
GDPR requires the data subject to be allowed to withdraw his or her consent
at any time unless personal data has already been processed pursuant to the
prior consent.99 Like the Privacy Rule, the GDPR also requires subjects to
be informed of their right to withdraw their consent prior to giving
consent.100
Where the GDPR is more stringent than the Privacy Rule is with respect
to the ease of withdrawal. The GDPR requires it to be as easy for the data
subject to withdraw his or her consent as it is for the subject to give
consent.101 HIPAA covered entities, on the other hand, frequently make it
more difficult for individuals to revoke their authorizations than to give their
authorization. For example, many covered hospitals require revocations to
be sent to the hospital through regular U.S. mail or presented in person to the
hospital’s Privacy Officer or other health information manager,102 although
they make their authorizations readily available for online completion and
96

45 C.F.R. § 164.508(b)(5).
Id. § 164.508(b)(5)(i), (ii).
98
Id. § 164.508(c)(2)(i)(A), (B).
99
EU GDPR, supra note 7, pmbl., ¶ 42 (stating that consent is not freely given if the
individual is unable to withdraw consent); id. art. 7, ¶ 3 (“The data subject shall have the right
to withdraw his or her consent at any time. The withdrawal of consent shall not affect the
lawfulness of processing based on consent before its withdrawal. Prior to giving consent, the
data subject shall be informed thereof. It shall be as easy to withdraw as to give consent.”).
100
Id. art. 7, ¶ 3.
101
Id.
102
See, e.g., Protected Health Information (PHI) Release Authorization, U. MED. CTR. 1,
https://www.umcsn.com/Common/Documents/authorization_disclose_health_info.pdf (last
visited Apr. 17, 2017) (“Revocation must be made in writing and presented or mailed to the
UMC Health Information Management Department at the following address: 1800 W.
Charleston Blvd., Las Vegas, Nevada 89102.”) (emphasis in original).
97
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submission.103
E. Marketing
Another point of comparison is that of marketing. If a communication
falls within the Privacy Rule’s definition of marketing,104 the Privacy Rule
prohibits a covered entity or BA from using or disclosing an individual’s PHI
for marketing unless the individual signs a specific authorization form noting
that the purpose of the use or disclosure is marketing and stating whether any
remuneration associated with the marketing exists,105 unless an exception to
the marketing authorization requirement applies.106
The GDPR is similar in terms of its dislike for what it calls “direct
marketing,” requiring the processing of personal data for direct marketing to
be “explicitly brought to the attention of the data subject,” requiring it to be
“presented clearly and separately from any other information,” giving the
data subject a clear right to object to the processing of his or her personal
data for direct marketing, and actually setting forth a prohibition against
marketing following such an objection.107

103
See, e.g., Authorization for Release of Health Information Pursuant to HIPAA, OCA
Official Form No.: 960, N.Y. ST. DEP’T HEALTH, http://www.nycourts.gov/forms/hipaa
_fillable.pdf (last visited Apr. 17, 2017) (offering a fillable, electronic HIPAA-compliant
authorization form).
104
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.501 (2016)
(defining marketing as the making of a communication about a product or service that
encourages recipients of the communication to purchase or use the product or service;
excluding from the definition of marketing communications made for purposes of: (1)
Providing refill reminders or otherwise communicating about a drug or biologic that is
currently being prescribed for the individual, but only if any financial remuneration received
by the covered entity in exchange for making the communication is reasonably related to the
covered entity’s cost of making the communication; (2) For the following treatment and health
care operations purposes, except where the covered entity receives financial remuneration in
exchange for making the communication: (A) For treatment of an individual by a health care
provider, including case management or care coordination for the individual, or to direct or
recommend alternative treatments, therapies, health care providers, or settings of care to the
individual; (B) To describe a health-related product or service (or payment for such product
or service) that is provided by, or included in a plan of benefits of, the covered entity making
the communication, including communications about: the entities participating in a health
care provider network or health plan network; replacement of, or enhancements to, a health
plan; and health-related products or services available only to a health plan enrollee that add
value to, but are not part of, a plan of benefits; or (C) For case management or care
coordination, contacting of individuals with information about treatment alternatives, and
related functions to the extent these activities do not fall within the definition of treatment).
105
Id. § 164.508(a)(3)(i), (ii).
106
Id. § 164.508(a)(3)(i)(A), (B).
107
EU GDPR, supra note 7, pmbl., ¶ 7; id. art. 21, ¶¶ 2, 3.

TOVINO (DO NOT DELETE)

990

8/8/2017 7:09 PM

SETON HALL LAW REVIEW

[Vol. 47:973

IV. RIGHTS OF AMENDMENT AND RECTIFICATION
Under the Privacy Rule, an individual generally has the right to have a
covered entity amend PHI or a record about the individual for as long as the
PHI is maintained in the designated record set.108 There are several
exceptions to this right. For example, a covered entity is permitted to deny
a request for amendment if the information is, indeed, accurate and
complete,109 or if the covered entity that is being asked to amend the
information did not create the information.110 Thus, the right is best framed
as a right to have amended incorrect or incomplete PHI by the creator of the
PHI. Individuals must be told of this right through their covered entities’
notices of privacy practices (NOPP).111
The GDPR has a rectification provision that is almost identical to the
Privacy Rule’s amendment provision. That is, the GDPR gives data subjects
the right to obtain rectification of inaccurate personal data from the controller
without undue delay and “the right to have incomplete personal data
completed, including by means of providing a supplementary statement.”112
The EU states in the Preamble to the GDPR that, “[e]very reasonable step
should be taken to ensure that personal data which are inaccurate are rectified
or deleted.”113 Like the NOPP requirement, the GDPR also requires data
controllers, at the time when personal data are obtained and even when
personal data are not obtained, to provide the data subject with information
regarding his or her right to request rectification.114
V. RIGHT TO ERASURE
One area where the Privacy Rule and the GDPR are very different is
with respect to the GDPR’s right to erasure, also called the right to be
forgotten.115 This right gives data subjects the ability to obtain from the
controller the erasure of personal data concerning him or her without undue
delay when one of the following illustrative, but not exhaustive, grounds
applies:
(a) the personal data are no longer necessary in relation to the
purposes for which they were collected or otherwise
processed; . . . (c) the data subject objects to processing . . . and
108

Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.526(a)(1)

(2016).
109
110
111
112
113
114
115

Id. § 164.526(a)(2)(iv).
Id. § 164.526(a)(2)(i).
Id. § 164.520(b)(1)(iv)(D).
EU GDPR, supra note 7, art. 16.
Id. pmbl., ¶ 39.
Id. art. 13, ¶ 2(b); id. art. 14, ¶ 2(c).
Id. art. 17.
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there are no overriding legitimate grounds for the processing; . . .
(d) the personal data have been unlawfully processed;
(e) the personal data have to be erased for compliance with a legal
obligation in Union or Member State law to which the controller
is subject.116
The GDPR further requires controllers to establish modalities,
including electronic request modalities, that facilitate the exercise of the right
to erasure of personal data.117
The Privacy Rule not only does not contain a right to erasure, but it also
does not modify federal and state medical record and other record retention
requirements. For example, the federal Medicare Conditions of Participation
require Medicare-participating hospitals to maintain hospital medical
records for five years.118 Many state medical practice acts require physicians
licensed in those states to maintain their own medical records for a set period,
such as seven years.119 In addition to federal and state medical record
retention requirements, there exist other health compliance record retention
requirements. For example, the Privacy Rule requires covered entities to
maintain documentation required by the Privacy Rule for six years from the
date when the documentation was created or was last in effect, whichever is
later, even if the patient or insured no longer has contact with the covered
entity.120
The GDPR does have exceptions to the right to erasure that address
situations in which retention is: (1) necessary to comply with a legal
obligation under Union or Member State law; (2) desirable for public health
reasons; or (3) desirable for scientific archiving reasons.121 These three
illustrative exceptions somewhat map on to the medical record and HIPAA
documentation maintenance requirements discussed immediately above.
Again, however, note the difference in approach. That is, general federal
and state health law and the Privacy Rule require the maintenance of medical
records and HIPAA documentation for a certain period of time. The GDPR
requires erasure except when an exception applies.

116

Id. art. 17(1)(a), (c), (d) & (e).
Id. pmbl., ¶ 59.
118
Conditions of Participation for Hospitals, 42 C.F.R. § 482.24(b)(1) (2016).
119
See, e.g., 22 TEX. ADMIN. CODE § 165.1(b)(1) (2016).
120
Privacy of Individually Identifiable Information, 45 C.F.R. § 164.530(j)(2) (2016).
121
See EU GDPR, supra note 7, art. 17, ¶ 3, for a list of all the exceptions to the right to
erasure.
117
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CONCLUSIONS
This Article has compared and contrasted the Privacy Rule and the
GDPR in three contexts, including authorization and consent, amendment
and rectification, and erasure. There are many similarities between the
concepts of authorization under the Privacy Rule and consent under the
GDPR. Obvious similarities include: (1) the expression of concern relating
to clarity and separation of presentation of the authorization under the
Privacy Rule and consent under the GDPR; (2) the prohibition of
conditioning services on an authorization under the Privacy Rule and the
assessment of such conditioning with respect to the voluntariness of consent
under the GDPR; (3) the right of an individual to revoke an authorization
under the Privacy Rule and to withdraw a consent under the GDPR; and (4)
significant concerns relating to the use and disclosure of PHI for marketing
under the Privacy Rule and the processing of personal data for direct
marketing under the GDPR.
The terminology, organization, and presentation of these concerns,
prohibitions, and rights in the Privacy Rule and the GDPR certainly are
different. The most notable difference—and the best illustration of such a
difference—is the Privacy Rule’s heavy-handed regulation of the content of
the authorization, including the six core elements and three required
statements that must be in every authorization.
It would be tempting to say that the Privacy Rule is, across the board,
more detailed and directive than the GDPR. For example, the Privacy Rule
contains a strong prohibition against combining authorizations with other
documents, whereas the GDPR allows consent to be presented in the context
of a written declaration concerning other matters so long as the request for
consent is presented in a manner that is clearly distinguishable from such
other matters. However, the GDPR does contain greater particularity and
regulatory rigidity in some contexts, including its requirement relating to the
ease of consent withdrawal.
With respect to the rights of amendment and rectification of inaccurate
or incomplete data, the Privacy Rule and the GDPR are very similar. The
regulatory language––amendment versus rectification––is the biggest
difference. A significant difference, however, lies in the GDPR’s right to
erasure and the lack of comparable language in the Privacy Rule. In general,
federal and state health law, including the Privacy Rule, require retention of
medical records, billing records, compliance records, and other records for
at least five years, if not longer. There are important clinical reasons for
these record retention requirements. Clinicians need to know, for example,
whether a patient is allergic to a drug or has had an adverse drug reaction in
the past, and older medical records are critical in terms of providing this
information and preventing drug and other injuries.
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Health insurers, too, need to maintain billing and payment records for
purposes of determining whether patients have satisfied their annual
deductibles, have met their annual out-of-pocket maximums and, if President
Trump repeals the Affordable Care Act, whether insureds or applicants for
insurance have preexisting health conditions that could make them ineligible
for insurance coverage of a future illness.
Health oversight agencies, including the Centers for Medicare and
Medicaid Services, the Office for Civil Rights, and the Drug Enforcement
Agency, also need billing and other administrative records to identify health
care fraud and abuse, to detect privacy violations, and to become aware of
problematic prescription patterns.
In summary, the obligation to maintain and the ability to produce
health-related records upon request is critical to the smooth functioning of
the health care delivery system as well as the health care financing system,
helping to explain some of the key differences between the GDPR and the
Privacy Rule, especially with respect to erasure.

